Stay updated on Blinatumomab & Pembrolizumab in B-ALL Clinical Trial

Sign up to get notified when there's something new on the Blinatumomab & Pembrolizumab in B-ALL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Blinatumomab & Pembrolizumab in B-ALL Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4, representing a new metadata version of the record rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-05-16T09:05:24.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page footer has been updated to reflect a newer ClinicalTrials.gov release revision (v3.5.3 instead of v3.5.2), indicating a version change for the site display rather than a change to the study record.
    Difference
    0.1%
    Check dated 2026-04-25T05:29:40.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.5.2 updated from v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-18T03:48:38.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-20T07:01:07.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-05T19:23:24.000Z thumbnail image
  9. Check
    107 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed, replacing the previous Revision: v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-12T01:39:46.000Z thumbnail image

Stay in the know with updates to Blinatumomab & Pembrolizumab in B-ALL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Blinatumomab & Pembrolizumab in B-ALL Clinical Trial page.